Brighton Securities’s Eli Lilly LLY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$267K Buy
+223
New +$228K 0.11% 33
2026
Q1
Sell
-247
Closed -$265K 52
2025
Q4
$265K Sell
247
-41
-14% -$39.2K 0.13% 31
2025
Q3
$220K Sell
288
-25
-8% -$18.6K 0.11% 54
2025
Q2
$244K Sell
313
-128
-29% -$99.5K 0.13% 61
2025
Q1
$364K Buy
441
+81
+23% +$67.4K 0.18% 41
2024
Q4
$278K Buy
+360
New +$298K 0.14% 52

Other funds holding LLY

Brighton Securities's LLY Position: Q2 2026 in Review

Brighton Securities opened a new position in Eli Lilly (LLY) in Q2 2026: 223 shares worth $267K. The stake represents 0.11% of the portfolio and ranks #33 among its holdings. This is a return to the name: Brighton Securities previously reported a position in LLY as recently as Q4 2025.

Brighton Securities first reported a position in LLY in Q4 2024 and has held it in 6 quarters since. The position peaked at $364K in Q1 2025. 4,593 funds tracked by Wall St. Rank hold LLY as of Q2 2026.

  • Brighton Securities held 223 shares of Eli Lilly worth $267K as of Q2 2026.
  • Eli Lilly was a new Brighton Securities position in Q2 2026.
  • Eli Lilly made up 0.11% of Brighton Securities's portfolio in Q2 2026, its #33 holding.
  • Brighton Securities first reported a position in Eli Lilly in Q4 2024 and has held it in 6 quarters since.
  • Brighton Securities's Eli Lilly position peaked at $364K in Q1 2025.
  • 4,593 funds tracked by Wall St. Rank held Eli Lilly as of Q2 2026.

Based on Brighton Securities's 13F filing for Q2 2026, filed 7 Jul 2026.